Ohio Medical Marijuana Task Force Committee Holds First Meeting

by Benesch

[co-author: Ted Bibart]

The Ohio House of Representatives’ Medical Marijuana Task Force (“Task Force”) convened its first meeting on Thursday, January 28, 2016 at the state capitol, and members of Benesch were in attendance.

The Task Force was formally announced by House Speaker Cliff Rosenberger (R-Clarksville) in early January 2016, with the stated purpose of creating a bipartisan task force “to vet all sides of the issue” of medical cannabis use. The Task Force is intended to work in partnership with various business groups, medical experts, issue advocates, state legislators and others in considering these matters.

The Task Force meetings will attempt to gather information and share policy perspectives from experts regarding a potential legislative and regulatory framework for the provision of medical cannabis to patients in Ohio. The Task Force is tasked with making a legislative proposal for consideration by the full House of Representatives by March 31, 2016.

The Task Force’s initial meeting was focused on procedural and organizational matters. No testimony was given by interested parties, but opening statements were provided from each of the Task Force members in attendance.[2]  State Representative Kirk Schuring (R-Canton) echoed prior statements by Speaker Rosenberger – that the Ohio legislature has heard from Ohioans all over the state who desire to have “a conversation” regarding the use of cannabis for medicinal purposes, and that the Task Force’s goal is to “bring to the forefront” opinions, information and knowledge on all sides of the issue.

Future meetings of the Task Force are anticipated to include more substantive engagement and testimony from experts on all sides of the topic. The Task Force will hold six more meetings prior to its March 31st reporting deadline, which can be expected to last approximately three hours each. Subsequent meetings will be held at the Ohio Statehouse on the following dates and times:

  • Thursday, February 11th at 3 p.m.
  • Thursday, February 18th at 7 p.m.
  • Thursday, February 25th at 7 p.m.
  • Thursday, March 10th at 7 p.m.
  • Thursday, March 17th at 3 p.m.
  • Thursday, March 31st at 3 p.m.

All of the Task Force members in attendance stressed an open mindedness with respect to any preconceived notions of cannabis. The fifteen-member Task Force is chaired by Rep. Schuring and includes the following additional legislators and other interested parties chosen by Speaker Rosenberger and Rep. Schuring:

  1. State Representative, and physician, Dr. Steve Huffman (R-Tipp City)
  2. State Representative Dan Ramos (D-Lorain)
  3.  Dr. Brian Santin, of the Ohio State Medical Association
  4. Nick Lashutka, president of the Ohio Children’s Hospital Association
  5. Betty Montgomery, former Ohio Attorney General
  6. Chris Stock, issue advocate and primary author of Issue 3
  7. Jimmy Gould, co-founder of ResponsibleOhio / Issue 3
  8. Bill Sopko, chair of the Ohio Manufacturers’ Association
  9. Lora Miller, Ohio Council of Retail Merchants
  10. Linda Hondros, Ohio Chamber of Commerce
  11. Matt Szollosi, Affiliated Construction Trades (ACT OHIO)
  12. Larry Moliterno, Ohio Alliance of Recovery Providers
  13. Gary Wolske, Fraternal Order of Police of Ohio (FOP)
  14. Matt Lutz, Muskingum County Sheriff and third vice president of the Buckeye State Sheriffs’ Association

The Ohio legislature’s actions in creating the Task Force (along with a parallel “town hall” style information-gathering effort in the Ohio Senate) are largely in response to increased interest in the topic of medical cannabis from various interests across Ohio, including the controversial “Issue 3” ballot initiative backed by the group Responsible Ohio, which failed to legalize recreational and medical cannabis use last November. Such efforts are set against the backdrop of a rapidly changing national landscape on the regulatory treatment of medical, recreational and industrial uses for the cannabis plant.  Twenty-three states have already legalized some form of medical cannabis use (including several of Ohio’s neighbors, such as Michigan, New York, and Illinois) and four states and the nation’s capital, Washington, D.C., have also legalized recreational use of cannabis.

If medical cannabis use is legalized in some capacity in Ohio, whether by the legislature or through one of several ballot initiatives being contemplated by varying interest groups, it could have broad impacts on medical professionals, patients, businesses, employers and Ohio residents generally. By getting ahead of the issue on the legislative side, the Ohio legislature may be able to better control the resulting legal framework and market structure than it would if medical or recreational cannabis were approved by voters through a constitutional amendment adopted by ballot initiative.

Benesch will continue to follow developments in the Task Force, the parallel legislative initiative in the Ohio Senate, as well as the various cannabis-related ballot initiatives being considered by various groups in Ohio.

[1] Ted Bibart is a law clerk at Benesch and is not admitted to practice law.

[2] Not present for the initial meeting of the Task Force were Betty Montgomery, former Ohio Attorney General, and Matt Szollosi, representative of Affiliated Construction Trades (ACT OHIO).

Written by:


Benesch on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.